Resources

Research conducted by Pioneer Group sheds light on the current investment trends shaping the life sciences landscape, offering insights into where capital is being allocated and what it means for the sector.

With a little over eight weeks to go to London Life Sciences Week (LLSW), we are launching a new website - lifesciencesweek.london - and lifting the lid on all that is happening to make the UK the place to be for life sciences this November. Continue reading for updates on NHS, £12 million Innovate UK funding, and more!

This week I’ve been engaging with City and Government figures seeking to develop practical measures enabling UK life science to deliver our full growth potential. The key autumn dates remain the Government’s International Investment Summit on 14 October and the Budget on 30 October but the debate about what should be in this is already well underway.

The BIA partnered with KQ Labs to host our Techbioboost event.

Greig Rooney, Managing Director at Valneva Scotland, writes about his experience getting malaria as a child and its impact on his life.

It’s a back-to-school feel with a bang for me this week as the landscape of the Association’s work til Christmas comes into sharp focus. Read on for our proposals for a sector-by-sector approach to analyse the effectiveness of R&D tax reliefs, turning health into economic growth, pandemics and more!

This week’s update pays tribute to UK biotech's driving force Dave Chiswell, previews a packed autumn events calendar, and highlights exciting new initiatives.

Following on from our roundtable in April of this year, Amrita Saha (left) and Anabel Marin (right) from the Institute of Development Studies (IDS) have written a blog discuss the lessons to be learnt from the UK's Covid-19 Vaccine Response. ​

This special summer newscast brings you up to date with the new UK government's engagement with life sciences, snapshots latest financing figures and showcases new BIA capacity through our new online presence.

In an ever-evolving life science industry, understanding compensation trends and having access to real-time data is not just a necessity—it's a strategic advantage. At J.Thelander Consulting, we are thrilled to announce our exclusive partnership with the BioIndustry Association (BIA).

This year RNID have been chosen as the BIA’s charity partner of the year. This partnership gives us a unique platform to shine the light on the huge opportunities that exist for hearing therapeutics.

In this blog, Jonathan Tobin, Partner at Brandon Capital, discusses the firm's recent close of its sixth fund at A$270 million, bringing its total assets under management to over A$1.25 billion. Jonathan also shares his thoughts on strategically bridging the gap and connecting with global players like Australia, New Zealand, the UK, and the US.

It is a fantastic way to start the week with news of Europe’s largest Series A biotech spin-out this year from the UK. Congratulations to Myricx Bio, an Imperial College London and Francis Crick Institute spin-out company focusing on a novel class of payloads for antibody-drug conjugates (ADCs), for announcing their Series A financing of £90 million.

In this blog, PIR International presents an interview with Anja Harmeier, CEO of Rewind Therapeutics, as part of their BioLeader interview series.

I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.

Over the past nine years, Dr Tony Bradshaw, Managing Director of Biosocius, has collected data from three distinct projects within the biotechnology sector. This effort has yielded unique and valuable insights that can help professionals thrive and build sustainable, fulfilling careers. By analysing behavioural profiles and consulting with industry experts, we can better understand the evolving demands of leadership in bioscience.

Molly Andrews of the UK Dementia Research Institute, Priya Kalia of SciTribe, and Miranda Weston-Smith of BioBeat highlight the urgent need for innovative digital solutions and investments in the accurate diagnosis and effective treatment of neurodegenerative diseases, as emphasised at BioBeat24.

In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.

Last week saw the key parties launch their general election manifestoes. This week sees a set piece hosting debate with the core parties talking about their approach to science and innovation at a live hustings at the Royal Society.